Reuters logo
BRIEF-Matrx Pharmaceuticals Q4 2016 net result turns to loss of 4.9 mln zlotys yoy
May 8, 2017 / 12:47 PM / 7 months ago

BRIEF-Matrx Pharmaceuticals Q4 2016 net result turns to loss of 4.9 mln zlotys yoy

May 8 (Reuters) - MATRX PHARMACEUTICALS SA:

* Q4 2016 NET LOSS OF 4.9 MILLION ZLOTYS VERSUS PROFIT OF 80.7 MILLION ZLOTYS A YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below